Cetera Advisor Networks’s Avenue Therapeutics ATXI Stock Holding History
Bought
Maintained
Sold
Other funds holding ATXI
Cetera Advisor Networks's ATXI Position: Q3 2022 in Review
Cetera Advisor Networks sold out of Avenue Therapeutics (ATXI) in Q3 2022, closing a stake of 10 shares — an estimated $3K sold.
Cetera Advisor Networks first reported a position in ATXI in Q2 2022 and held it in 1 quarter. The position peaked at $3K in Q2 2022. 10 funds tracked by Wall St. Rank hold ATXI as of Q3 2022.
- Cetera Advisor Networks reported no remaining Avenue Therapeutics position as of Q3 2022 after selling out during the quarter.
- Cetera Advisor Networks sold 10 Avenue Therapeutics shares in Q3 2022, an estimated $3K.
- Cetera Advisor Networks first reported a position in Avenue Therapeutics in Q2 2022 and held it in 1 quarter.
- Cetera Advisor Networks's Avenue Therapeutics position peaked at $3K in Q2 2022.
- 10 funds tracked by Wall St. Rank held Avenue Therapeutics as of Q3 2022.
Based on Cetera Advisor Networks's 13F filing for Q3 2022, filed 14 Nov 2022.